Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: An in vitro study

Rheumatology

Volumn 42, Issue 6, 2003, Pages 784-790

  Hooiveld, M J J ^a,b   Roosendaal, G ^b   van den Berg, H M ^b   Bijlsma, J W J ^a   Lafeber, F P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cartilage damage; Hydroxyl radical formation; Interleukin 1 ; Joint damage; Mononuclear cells; Red blood cells

Indexed keywords

ANTIOXIDANT; CD14 ANTIGEN; DIMETHYL SULFOXIDE; EBSELEN; HEMOGLOBIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INTERLEUKIN 1BETA; IRON; PROTEOGLYCAN; INTERLEUKIN 1;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CHONDROPATHY; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HEMARTHROSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MALE; MONOCYTE; MONONUCLEAR CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; REGULATORY MECHANISM; SAMPLING; STATISTICAL ANALYSIS; TISSUE CULTURE; ARTICULAR CARTILAGE; BIOSYNTHESIS; BLOOD CELL; CULTURE TECHNIQUE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; ANTIOXIDANTS; BLOOD CELLS; CARTILAGE, ARTICULAR; CULTURE TECHNIQUES; ERYTHROCYTES; FEMALE; HEMARTHROSIS; HEMOGLOBINS; HUMANS; HYDROXYL RADICAL; INTERLEUKIN-1; IRON; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROTEOGLYCANS;

EID: 0038603006     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg220     Document Type: Article

References (38)

1. Madhok R, York J, Sturrock RD. Haemophilic arthritis. Ann Rheum Dis 1991;50:588-91.
2. Roosendaal G, Vianen ME, Marx JJ, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: a human in vitro study. Arthritis Rheum 1999;42:1025-32.
3. Roosendaal G, TeKoppele JM, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: a canine in vivo study. Arthritis Rheum 1999; 42:1033-9.
4. Konttinen YT, Ainola M, Valleala H et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691-7.
5. van den Berg WB, Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I. Baillieres Best Pract Res Clin Rheumatol 1999;13:577-97.
6. Blanco Garcia FJ. Catabolic events in osteoarthritic cartilage. Osteoarthritis Cartilage 1999;7:308-9.
7. Goldring MB. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2000;2:459-65.
8. Elliott S, Cawston T. The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders. Drugs Aging 2001;18:87-99.
9. Fernandez-Palazzi F, Rivas S, Viso R, de Bosch NB, de Saez AR, Boadas A. Synovectomy with rifampicin in haemophilic haemarthrosis. Haemophilia 2000;6:562-5.
10. Rodriguez-Merchan EC. Methods to treat chronic haemophilic synovitis. Haemophilia 2001;7:1-5.
11. Siegel HJ, Luck JV Jr, Siegel ME, Quinones C. Phosphate-32 colloid radiosynovectomy in hemophilia: outcome of 125 procedures. Clin Orthop 2001;409-17.
12. Roosendaal G, Mauser-Bunschoten EP, de Kleijn P et al. Synovium in haemophilic arthropathy. Haemophilia 1998; 4:502-5.
13. Roosendaal G, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Cartilage damage as a result of hemarthrosis in a human in vitro model. J Rheumatol 1997; 24:1350-4.
14. Roosendaal G, Vianen ME, Wenting MJ et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br 1998; 80:540-5.
15. van der Kraan PM, van den Berg WB. Anabolic and destructive mediators in osteoarthritis. Curr Opin Clin Nutr Metab Care 2000;3:205-11.
16. van den Berg WB. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin Arthritis Rheum 2001;30:7-16.
17. Nietfeld JJ, Wilbrink B, den Otter W, Huber J, Huber-Bruning O. The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants. J Rheumatol 1990;17:818-26.
18. Wilbrink B, Nietfeld JJ, den Otter W, Van Roy JL, Bijlsma JW, Huber-Bruning O. Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Br J Rheumatol 1991; 30:265-71.
19. Schalkwijk J, van den Berg WB, van de Putte LB, Joosten LA. Hydrogen peroxide suppresses the proteoglycan synthesis of intact articular cartilage. J Rheumatol 1985;12:205-10.
20. Tiku ML, Yan YP, Chen KY. Hydroxyl radical formation in chondrocytes and cartilage as detected by electron paramagnetic resonance spectroscopy using spin trapping reagents. Free Radic Res 1998;29:177-87.
21. Templeton DM. Therapeutic use of chelating agents in iron overload. In: Goyer RA, Cherian MG, eds. Toxicology of metals: biochemical aspects. Berlin: Springer Verlag, 1995:305-31.
22. Tiku ML, Liesch JB, Robertson FM. Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. J Immunol 1990;145:690-6.
23. Moura E, Noordermeer MA, Verhoeven N, Verheul AF, Marx JJ. Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood 1998;92:2511-9.
24. Rippey JJ, Hill RR, Lurie A, Sweet MB, Thonar EJ, Handelsman JE. Articular cartilage degradation and the pathology of haemophilic arthropathy. S Afr Med J 1978;54:345-51.
25. Choi YC, Hough AJ, Morris GM, Sokoloff L. Experimental siderosis of articular chondrocytes cultured in vitro. Arthritis Rheum 1981;24:809-23.
26. 4 due to Fe(III), Fe(II), ferritin and haemoglobin in vitro. Virchows Arch B Cell Pathol Incl Mol Pathol 1982;38:297-306.
27. van Roon JA, van Eden W, Van Roy JL, Lafeber FJ, Bijlsma JW. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest 1997;100:459-63.
28. Lafeber FP, Vander Kraan PM, Van Roy JL, Huber-Bruning O, Bijlsma JW. Articular cartilage explant culture; an appropriate in vitro system to compare osteoarthritic and normal human cartilage. Connect Tissue Res 1993;29:287-99.
29. Sambrano GR, Terpstra V, Steinberg D. Independent mechanisms for macrophage binding and macrophage phagocytosis of damaged erythrocytes. Evidence of receptor cooperativity. Arterioscler Thromb Vasc Biol 1997; 17:3442-8.
30. Madhok R, Bennett D, Sturrock RD, Forbes CD. Mechanisms of joint damage in an experimental model of hemophilic arthritis. Arthritis Rheum 1988;31:1148-55.
31. Berkovitch M, Laxer RM, Inman R et al. Arthropathy in thalassaemia patients receiving deferiprone. Lancet 1994; 343:1471-2.
32. Lutz HU. Red cell clearance (a review). Biomed Biochim Acta 1987;46:S65-S71.
33. Bratosin D, Mazurier J, Slomianny C, Aminoff D, Montreuil J. Molecular mechanisms of erythrophagocytosis: flow cytometric quantitation of in vitro erythrocyte phagocytosis by macrophages. Cytometry 1997;30:269-74.
34. Stohs SJ. The role of free radicals in toxicity and disease. J Basic Clin Physiol Pharmacol 1995;6:205-28.
35. Nietfeld JJ, Huber-Bruning O, Bylsma JW. Cytokines and proteoglycans. EXS 1994;70:215-42.
36. Tiku ML, Gupta S, Deshmukh DR. Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic Res 1999; 30:395-405.
37. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995; 146:75-85.
38. Huisman A, Vos I, Van Faassen EE et al. Anti-inflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: modulation of inducible nitric oxide synthase. FASEB J 2000;16:1135-7.